Development of HM30181 mesylate-loaded microcapsules as novel P-glycoprotein inhibitor
- Title
- Development of HM30181 mesylate-loaded microcapsules as novel P-glycoprotein inhibitor
- Author
- 김진철
- Advisor(s)
- 최한곤
- Issue Date
- 2016-08
- Publisher
- 한양대학교
- Degree
- Doctor
- Abstract
- The purpose of this study was to develop HM30181 mesylate (HM30181M)-loaded microcapsules as a novel P-glycoprotein inhibitor for enhancing the oral absorption
of paclitaxel. The effect of various carriers including hydrophilic polymers and solvents on the solubility of HM30181M were evaluated. Among the hydrophilic
polymers and solvents tested, HPMC and methylene chloride (and ethanol) provided the highest HM30181M solubility. Numerous HM30181M-loaded microcapsules were prepared with HPMC, silicon dioxide and acidifying agents using a spray-drying technique, and their solubility, dissolution and physicochemical properties were evaluated. Furthermore, a pharmacokinetic study was performed after oral administration of paclitaxel alone, simultaneously with HM30181M powder or HM30181M-loaded microcapsules to rats. Among the acidifying agents investigated, phosphoric acid provided the best improvement in the solubility and dissolution of HM30181M. Moreover, the microcapsule composed of HM30181M, HPMC, silicon dioxide and phosphoric acid at a weight
ratio of 3:6:3:2 remarkably enhanced the solubility and dissolution of HM30181M compared with the HM30181M powder alone. The microcapsules were spherical
in shape, had a reduced particle size of about 7 μm, and contained HM30181M in an amorphous state. Furthermore, this microcapsule significantly enhanced HM30181M absorption, making it about 1.7-fold faster and 1.6-fold greater after simultaneous administration, leading to about 70- and 2-fold fold improved oral bioavailability of paclitaxel compared with paclitaxel alone and the simultaneous
administration with HM30181M powder, respectively. Thus, this novel microcapsule could be a potential candidate for effective P-glycoprotein inhibition during paclitaxel administration.
- URI
- https://repository.hanyang.ac.kr/handle/20.500.11754/125995http://hanyang.dcollection.net/common/orgView/200000429258
- Appears in Collections:
- GRADUATE SCHOOL[S](대학원) > PHARMACY(약학과) > Theses (Ph.D.)
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML